Large-scale testing (Phase 3)Looking for participantsNCT07082192
What this trial is testing
Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Shanghai Zhimeng Biopharma, Inc. 240